Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NexgenRx ( (TSE:NXG) ) has provided an announcement.
NexgenRx has announced a dividend of $0.005 per share for its outstanding common and series 1 preferred shares, with payments scheduled for December 19, 2025, and January 1, 2026, respectively. This move reflects the company’s stable financial position and commitment to returning value to its shareholders, potentially enhancing its attractiveness in the market.
More about NexgenRx
NexgenRx is Canada’s only independent full-service Third-Party Administrator and Technology Solutions Provider. The company offers proprietary front-end, eligibility, enrolment, hour bank, and mobile access capabilities, alongside state-of-the-art claims adjudication and full provider network coverage. These services are provided in a cost-effective SaaS model, targeting Plan Sponsors with sophisticated administration and health benefit technology applications.
Average Trading Volume: 18,606
Technical Sentiment Signal: Buy
Current Market Cap: C$29.87M
See more insights into NXG stock on TipRanks’ Stock Analysis page.